electroCore Inc. (NASDAQ: ECOR)
$15.7150
-1.8000 ( -11.61% ) 107.4K
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
Market Data
Open
$15.7150
Previous close
$17.5200
Volume
107.4K
Market cap
$105.54M
Day range
$15.7550 - $17.7750
52 week range
$5.2500 - $17.8900
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-k | Annual reports | 92 | Mar 13, 2024 |
4 | Insider transactions | 1 | Jan 18, 2024 |
4 | Insider transactions | 1 | Jan 17, 2024 |
8-k | 8K-related | 43 | Jan 16, 2024 |
4 | Insider transactions | 1 | Jan 03, 2024 |
3 | Insider transactions | 1 | Dec 18, 2023 |
8-k | 8K-related | 12 | Dec 14, 2023 |